جستجوی استاد راهنمای دانشگاهی

• Perinatal Epidemiology
• Reproductive Health
• Vitamin D Research
• +۵ مورد دیگر

Anne Marie Jukic, PhD, MSPH serves as an Adjunct Assistant Professor in the Department of Chronic Disease Epidemiology at the Yale School of Public Health. Her research focuses on perinatal epidemiology with emphasis on the pre-conception period, pregnancy outcomes, and child health. Dr. Jukic's research interests include: Early pregnancy events, particularly implantation and placental development Vitamin D's role in reproductive health and fertility Environmental exposures (phthalates and phenols) and their impact on pregnancy Menstrual cycle function as a vital sign for reproductive health Physical activity during pregnancy and pregnancy outcomes Her publications reveal strong trends in digital epidemiology, vitamin D research, and environmental impacts on reproductive health. Recent work leverages large digital cohorts to investigate menstrual patterns, PCOS prediction, and androgen excess across the lifespan. She maintains active collaborations with Norwegian research teams studying placental development and childhood neurodevelopment. Scientific recognition includes: Rising Star Award (2016) from Society for Pediatric and Perinatal Epidemiologic Research Young Investigator Award (2016) from Vitamin D Workshop NIEHS Paper of the Month (2015) Poster Award (2015) from Society for Epidemiologic Research Student Travel Award (2012) from Society for Epidemiologic Research Dr. Jukic directs research within the Yale Center for Perinatal, Pediatric and Environmental Epidemiology (CPPEE), investigating how environmental, genetic, and clinical factors impact pregnancy and childhood health. Her current projects include studies on ambient air pollution and miscarriage, vitamin D and cycle regularity, and microRNA in early placental development.

• Biosensors
• Bio-nanotechnology
• Bioregenerative Life Support
• +۴ مورد دیگر

Dr. D. Marshall Porterfield is a Professor of Agricultural & Biological Engineering at Purdue University, specializing in biosensors, bio-nanotechnology, and space biology. His research focuses on developing technologies for bioregenerative life support systems and nutrient delivery in microgravity environments. He served as NASA's Division Director for Space Life and Physical Sciences (2012-2016), pioneering initiatives like geneLAB and materialsLAB to advance space research utilization. His work bridges engineering and biology, with applications in space exploration and terrestrial challenges. Porterfield holds leadership roles in organizations like the American Society for Gravitational and Space Research and the Institute for Biological Engineering. He has authored over 100 peer-reviewed papers and holds patents in biosensor technology. Awards include the Halstead Investigator Award and election to the AIMBE College of Fellows. His research portfolio includes lab-on-a-chip devices, biomimetic sensors, and gravitational physiology studies, with recent emphasis on lunar agriculture and space radiation mitigation. His articles highlight advancements in space microbiology, extraterrestrial crop systems, and molecular responses to spaceflight. Key themes include optimizing oxygen delivery for hydroponics, detecting cancer biomarkers via microtest tech, and understanding aging in space environments. Porterfield collaborates across disciplines, leveraging Purdue's facilities like the Birck Nanotechnology Center and Discovery Park for interdisciplinary innovation.

Xiaonan ZHANGمشاهده پروفایل

دانشیار

• Virology
• Molecular Biology
• Translational Medicine
• +۴ مورد دیگر

Xiaonan ZHANG is an Associate Professor in the Faculty of Science and Technology at the University of Canberra, leading the Hepatitis B Virus (HBV) Group within the Centre for Research into Therapeutic Solutions. He holds a PhD from Fudan University (2012) and previously worked at the Shanghai Public Health Clinical Centre until 2021. His research focuses on HBV molecular pathogenesis, therapeutic vaccine development, and next-generation sequencing applications in viral infections. His work has advanced understanding of HBV’s clinical outcomes, including the discovery of Capsid-Antibody-Complexes (CACs) and their role in pathogenesis. Collaborations span institutions like the Peter Doherty Institute, University of Queensland, and international partners such as Fudan University and University of Duisburg-Essen. Key projects include: Development of therapeutic mRNA vaccines for chronic HBV Clinical evaluation of CAC assays in HBV/HIV co-infections Metagenomic sequencing for pathogen identification Research interests emphasize translational medicine, with contributions to H7N9 influenza and SARS-CoV-2 studies during the pandemic. His team pioneered real-world analyses of viral and host factors in COVID-19 outcomes. Current focus includes liver-resident immune cell dynamics and novel diagnostic assays for HBV nucleic acids. Publications highlight innovations in HBV cccDNA tracking, immune complex mechanisms, and exosome-mediated signaling. No scientific awards were explicitly listed in the provided texts. Xiaonan actively collaborates on grants and supervises PhD students, advancing interdisciplinary approaches to viral diseases.

Shankar Mukherjiمشاهده پروفایل

استادیار

• Biophysics
• Quantitative Biology
• Systems Biology
• +۳ مورد دیگر

Shankar Mukherji is an Assistant Professor of Physics at Washington University in St. Louis, affiliated with the Department of Physics and the Center for Quantum Leaps. His research integrates theoretical and experimental approaches to understand the design principles governing cellular function, with a focus on organelle biogenesis, spatial organization, and systems-level coordination. He holds a PhD in Biomedical Engineering from the Harvard-MIT Division of Health Science and Technology, and completed postdoctoral training at Harvard’s FAS Center for Systems Biology under Erin O’Shea. Key research themes include: (1) how cells regulate organelle abundance, size, and spatial distribution under developmental/environmental cues, (2) the interplay between organelle biogenesis and cellular physiology, and (3) engineering cellular decision-making to control organelle properties. His group employs advanced imaging, synthetic biology, and computational modeling techniques. Recent work emphasizes systems-level analysis of organelle networks, uncovering principles linking cellular growth to organelle allocation. Notable contributions include studies on stochastic fluctuations in organelle abundance, resource competition models, and the biophysical limits governing organelle formation. Courses taught include Biophysics Laboratory (Physics 360) and Calculus-based Physics (Physics 191). His research has been highlighted in high-impact journals like Cell Systems, Nature, and Science. Current projects explore nanodiamond-based quantum sensing for organelle detection and synthetic biology approaches to reprogram organelle biogenesis pathways.

Joshua Edelمشاهده پروفایل

استاد

• Analytical Chemistry
• Medical Biotechnology
• Human Biophysics
• +۳ مورد دیگر

Joshua Edel is a Professor of Biosensing & Analytical Sciences at Imperial College London's Department of Chemistry within the Faculty of Natural Sciences. He specializes in developing trace analyte analytical platforms, including bioanalytical sensors for clinical applications. His work focuses on single-molecule detection, nanopore sensors, and microfluidic systems. Edel has published over 180 research articles and secured prestigious grants like the ERC Starting Grant (2011) and ERC Consolidator Award (2017). His research spans nanobiotechnology, plasmonic sensors, and biosensor innovation. Education: PhD in developing single-molecule detection within microfluidic systems from Imperial College London (2003). Postdoctoral research at Cornell University (School of Applied and Engineering Physics) and a fellowship at Harvard University's Rowland Institute (single-molecule biophysics). Research Interests: Edel’s lab pioneers techniques such as high-throughput droplet microfluidics, optical/electrical single-molecule sensors, and plasmonic nanopore sensors. His work addresses challenges in diagnostics, nanoelectronics, and structural chemistry. Key areas include developing selective biosensors for clinical samples and advancing nanoscale probing technologies. Grants & Awards: ERC Starting Grant (2011): Rare event bioanalysis ERC Consolidator Award (2017): Selective single-molecule biosensors Funding from EPSRC, Wellcome Trust, and industrial partners Advising & Labs: Edel leads projects in Imperial’s Department of Chemistry and collaborates across disciplines. His lab develops cutting-edge tools like nanoscale tweezers for single-cell analysis and nanofluidic platforms for biomarker detection. He actively consults in biosensing technology.

• Biomedical polymers
• Nano-gene/drug carriers
• Biotherapy
• +۳ مورد دیگر

Prof. Huayu Tian is a Nan Qiang Distinguished Professor at the Department of Chemistry, College of Chemistry and Chemical Engineering, Xiamen University. With a Ph.D. in Polymer Chemistry and Physics from Changchun Institute of Applied Chemistry (CAS), he leads research in biomedical polymers and nanocarriers for gene/drug delivery. B.S. (1994-1998): Polymer Materials, Harbin Institute of Technology M.S. (1998-2000): Materials Science, Harbin Institute of Technology Ph.D. (2002-2005): Polymer Chemistry, Changchun Institute His work focuses on biomedical polymers , nanocarriers for gene therapy , nucleic acid vaccines , and immunotherapy , with applications in cancer treatment and sepsis management . Recent publications highlight photothermal-immunotherapy combinations , MOF-based drug systems , and microenvironment-responsive nanomaterials . Notable awards include: Jilin Province Natural Science Award (First Prize, 2021) National Outstanding Youth Fund (China) Youth Innovation Promotion Association, CAS (2016)

• Molecular Chaperones in Cancer
• Heat Shock Proteins (Hsp60, Hsp90, Hsp27)
• Thyroid Pathology
• +۵ مورد دیگر

Francesca Rappa is a Full Professor in the Department of Human Anatomy and Histology within the School of Medicine and Surgery at the University of Palermo. Her academic position (BIOS-12/A classification) centers on biomedicine, neuroscience, and advanced diagnostics with a focus on molecular mechanisms of disease. Her research spans multiple interconnected domains centered on stress response systems. Key interests include: Molecular chaperone networks (particularly Hsp60, Hsp90, Hsp27) in carcinogenesis Thyroid and colorectal cancer pathophysiology Glioblastoma multiforme molecular characterization Probiotic interventions for gut-liver-muscle axis disorders Nanovesicle-based therapeutics from citrus and tomatoes Diagnostic applications of heat shock proteins in inflammatory diseases Publication analysis reveals consistent focus on chaperone systems across cancer types (thyroid, salivary, colorectal, brain), with recent expansion into nutraceutical mechanisms involving citrus nanovesicles and golden tomatoes. Her 2023-2025 output shows increasing emphasis on multi-organ communication pathways (gut-brain, gut-liver-muscle) and industrial-scale therapeutic applications. Methodologically, she integrates immunohistochemistry, proteomics, and animal disease models. Teaching responsibilities include core anatomy courses for Medicine and Radiology programs: Anatomy I (10 CFU) and II (6 CFU) for Medicine Human Anatomy with Histology elements (6 CFU) for Radiology Integrated Anatomy/Biochemistry/Physiology modules (12 CFU) She actively supervises graduate research, with four theses directed between 2020-2024 covering celiac disease histopathology, stress protein interactions in colorectal cancer, glioblastoma biomarkers, and thyroid stress responses. Her laboratory work focuses on immunomorphological analysis of chaperone systems in tumor tissues and development of probiotic/nanovesicle interventions for metabolic and inflammatory conditions.

Chase Broederszمشاهده پروفایل

دانشیار

• Cell Migration
• Chromosome Organization
• Biopolymer Mechanics
• +۳ مورد دیگر

Chase Broedersz is an Associate Professor at Vrije Universiteit Amsterdam, affiliated with the Faculty of Science's Physics of Living Systems department and the LaserLaB - Energy research group. He leads interdisciplinary research on cell migration, chromosome mechanics, and active matter, combining experimental and theoretical approaches. His work contributes to UN Sustainable Development Goals related to health and innovation. Research Interests: Focus on cell migration dynamics , chromosome organization , biopolymer mechanics , and nonlinear elasticity . Recent studies explore bacterial chromosome topology, metastasis prevention mechanisms, and 3D nuclear deformation during cell movement. His methods include Hi-C data analysis, single-molecule tweezers, and computational modeling. Publications Trends: Recent work emphasizes chromosome condensation mechanics , active matter dynamics , and nonlinear elasticity in biopolymers . Key 2024-2025 studies include ion-mediated mitotic chromosome mechanics and metastasis suppression by miR-200c. Awards: None explicitly listed. Grants/Advising: Supervised one PhD thesis and contributes to datasets like biopolymer matrix nonlinear elasticity studies. Labs/Teams: Active in LaserLaB and collaborates internationally on cell migration and chromosome physics.

Vassilis P. Plagianakosمشاهده پروفایل

دانشیار

• Machine Learning
• Neural Networks
• Bioinformatics
• +۵ مورد دیگر

Vassilis P. Plagianakos is an Associate Professor at the Department of Computer Science and Biomedical Informatics, University of Thessaly, Greece. He has held visiting academic roles at the University of the Aegean, University of Patras, and University of Central Greece. He currently serves as the Department Head and Director of the postgraduate program Informatics and Computational Biomedicine in the School of Sciences. His research focuses on machine learning, neural networks, bioinformatics, and parallel computing with applications in healthcare and education. Education : Bachelor’s in Mathematics (1996), University of Patras Ph.D. in Mathematics (2003), University of Patras Research Interests : Plagianakos explores neural networks, evolutionary algorithms, and machine learning applications in bioinformatics, medical diagnosis, and educational technology. His work bridges computational methods with real-world challenges in healthcare (e.g., precision medicine) and STEM education (e.g., flipped classrooms, AI integration). Recent Trends in Publications : Recent work emphasizes predictive precision medicine using big data, blockchain scalability solutions, and AI ethics in automated content detection. He has pioneered methods like the HCER hierarchical clustering-ensemble regressor and developed tools for analyzing single-cell RNA sequencing data. Professional Activities : Member of IEEE Neural Networks Society, IEEE BBTC, and former Board Member of the Hellenic AI Society. Active in collaborative projects like CrowdHEALTH for policy-driven health data analytics.

Shoib Siddiquiمشاهده پروفایل

مدرس ارشد

• Cancer Biology
• Immunology
• Glycobiology
• +۴ مورد دیگر

Dr. Shoib Siddiqui is a Senior Lecturer at the University of Hertfordshire's School of Life and Medical Sciences, specializing in cancer biology, immunology, and glycobiology. Previously, he held positions at the American University of Ras Al Khaimah and conducted postdoctoral research at UC San Diego under Prof. Ajit Varki. His research focuses on sialic acids, Siglecs, and microRNA mechanisms in cancer, Alzheimer’s, and sepsis. He earned his Ph.D. from ETH Zurich, investigating neuropilin-2 in skin cancer progression. Education: Ph.D. in Vascular Biology, Immunology, and Cancer Biology (ETH Zurich, 2009–2013) M.Sc. in Biotechnology (IIT Bombay, 2008) Research Focus: Dr. Siddiqui’s work explores cancer progression pathways, tumor biomarkers, and novel therapies. Key areas include Siglec-sialoglycan interactions, microRNA targeting, and drug repurposing for colorectal cancer. His recent projects involve developing RNAi therapeutics and inhibitors for Siglec-15. Projects: Fluralaner as a Colorectal Cancer Therapeutic (2026–2027) ADAMTS-7 Inhibition for Coronary Artery Disease (2022) UK-China Mycotoxin Reduction Alliance (2022–2023) Publications: Over 39 peer-reviewed articles in journals like Journal of Clinical Investigation , PNAS , and Blood , with a focus on oncology, glycobiology, and immunology. Recent trends emphasize Siglec-targeted therapies, microRNA networks, and drug repurposing strategies. Awards: No formal awards listed, but noted for impactful publications in high-impact journals. Advising & Grants: Served as Principal Investigator (PI) on RNAi therapeutics and Co-Investigator (CoI) on Siglec-15 and ADAMTS-7 projects. Collaborations span international institutions and cross-disciplinary teams. Labs/Teams: Active in the Biosciences Research Group and Centre for Research in Mechanisms of Disease and Drug Discovery at UH. Collaborates with global researchers in glycobiology and oncology.

Alan Dombkowskiمشاهده پروفایل

استاد

• Molecular Neuroscience
• Genomics
• Bioinformatics
• +۴ مورد دیگر

Alan Dombkowski is a Professor of Pediatrics at Wayne State University School of Medicine, specializing in molecular mechanisms of neurological disorders through genomic and bioinformatic approaches. Key research focus: Epileptogenic potential of cortical tubers in Tuberous Sclerosis Complex (TSC) Methods: Next-gen sequencing, microarrays, proteomics, and epigenetic analysis of human brain tissue Current projects funded by federal grants examining microRNA regulation and therapeutic targets in epilepsy Recent publications span: 2024: Cisplatin-induced cochlear synaptic proteomics 2023: Multi-omic biomarkers for prostate cancer aggressiveness 2021: Exosomal miRNA in TSC epilepsy 2018: Neuroinflammatory mechanisms in pediatric epilepsy Collaborations include Harry Chugani (neuroimaging), Diane Chugani (neurochemistry), Eishi Asano (epileptology), and Paul Stemmer (molecular pharmacology).

Teresa A. Zimmersمشاهده پروفایل

استاد

• Cancer Cachexia
• Pancreatic Cancer
• Muscle Wasting and Atrophy
• +۷ مورد دیگر

Teresa A. Zimmers is a Professor at Indiana University with extensive expertise in cancer cachexia, muscle wasting, and translational oncology. She holds a Ph.D. from The Johns Hopkins University School of Medicine (2001), a B.S. from Massachusetts Institute of Technology (1990), and completed postdoctoral training at the University of Rochester (2001-2003). Dr. Zimmers leads prominent academic initiatives as President of the Cancer Cachexia Society and co-organizer of international conferences including the 2023 Cancer Cachexia Conference and 2024 Keystone Conference. Her multidisciplinary research focuses on: Molecular mechanisms of cancer cachexia and muscle atrophy Sex-specific differences in cancer progression Pancreatic cancer pathophysiology Inflammatory signaling in organ injury Translational approaches for metabolic wasting disorders She maintains active memberships in the American Association for Cancer Research, Shock Society, and Society on Sarcopenia, Cachexia and Wasting Diseases. Honors recognizing her contributions include: Alliance of Distinguished and Titled Professors (Indiana University, 2019) Sigma Xi Honor Society (2019) Cancer Researcher of the Year (Women’s Cancer Association, 2009) Distinguished Investigator Award (University of Miami, 2005)

Denise Doolanمشاهده پروفایل

استاد

• Molecular Immunology
• Vaccinology
• Infectious Diseases
• +۵ مورد دیگر

Professor Denise Doolan is an Affiliate Professor in The University of Queensland's School of Chemistry and Molecular Biosciences and Deputy Director (Research) at the Institute for Molecular Bioscience (IMB). She previously served as Deputy Director of the Australian Institute of Tropical Health and Medicine and Director of the JCU Centre for Molecular Therapeutics. Her research focuses on molecular immunology, vaccine development, and omics-based approaches to combat infectious and chronic diseases, particularly malaria and Epstein-Barr virus (EBV)-related malignancies. She leads cross-disciplinary programs in antigen discovery, host-pathogen immunity, and biomarker development, leveraging genome-based technologies and human disease models. Academic Positions: Affiliate Professor, Deputy Director (IMB), Affiliate of Centre for Superbug Solutions Executive Roles: President of International Society for Vaccines (2021–2023), Member of Australian Medical Research Advisory Board Her research interests include vaccine engineering, systems immunology, and therapeutic development. Key projects involve identifying EBV protein signatures linked to Multiple Sclerosis and malaria immunity profiling using controlled human infection models. She is renowned for her work in malaria immunology and omics-based diagnostics, recognized with Fellowships from the International Society for Vaccines and Australian Society of Parasitology. Recent publications highlight her work on EBV antibody responses in lymphomas, malaria vaccine candidates, and molecular diagnostics for vascular diseases. She actively supervises PhD students in areas like EBV-MS links and malaria systems immunology, supported by grants from NIH, MS Research Australia, and ARC. Scientific Awards: ISV Fellowship (2017), ASP Fellowship (2019) Grants: NIH-funded malaria vaccine projects, EBV-MS diagnostics (MS Research Australia) Her lab collaborates on developing point-of-care tests and next-generation vaccines, emphasizing translational research to address global health challenges.

Yehuda Ben-Shaharمشاهده پروفایل

استاد

• Behavioral Genetics
• Neurogenetics
• Insect Behavior
• +۴ مورد دیگر

Yehuda Ben-Shahar is a Professor of Biology at Washington University in St. Louis, where he has served since 2008. His research integrates behavioral, genetic, genomic, and molecular approaches to investigate the genetic architectures underlying animal behavior, primarily using Drosophila melanogaster and honey bees as model systems. He maintains laboratory facilities at the Bayer Laboratory (Room 406) and conducts field research at the Tyson Research Center. Ben-Shahar earned his PhD from the University of Illinois at Urbana-Champaign. His research focuses on how specific genes in neuronal circuits govern behaviors like feeding and mating decisions, with significant contributions to understanding honey bee social behavior evolution. Recent work centers on the gut microbiome's role in nestmate recognition and developing genetic tools for non-model insects. His publication record reveals consistent innovation in behavioral genetics, with recent emphasis shifting toward microbial influences on social behavior and neural circuit analysis. Early work established foundational insights into gene-behavior relationships, while current research explores chemosensory mechanisms across insect and mammalian systems. Scientific recognition includes: Multiple Faculty of 1000 'Must read' designations (2002, 2007, 2009) Cover features in Science (2009) and Journal of Experimental Biology (2002) 'Mutant of the Month' in Nature Genetics (2006) Extensive media coverage including NPR, CBC Radio, and major newspapers Ben-Shahar mentors graduate students including Cassie Vernier (whose 2020 Science Advances paper defined gut microbiome roles in hive membership) and has supervised numerous undergraduates. His lab operates through collaborative grants supporting research at the intersection of genetics, neuroscience, and social behavior. The Ben-Shahar Lab maintains active research teams at the Bayer Laboratory for molecular work and the Tyson Research Center for honey bee studies, with recent projects involving cyborg locust development and odor-guided navigation research.

• Synthetic Biology
• Chemical Engineering
• Biomedical Engineering
• +۹ مورد دیگر

Dr. Francesca Ceroni is a Senior Lecturer in the Department of Chemical Engineering at Imperial College London, part of the Faculty of Engineering. She holds affiliations with the Centre for Synthetic Biology, the CRUK Convergence Science Centre, and the UKRI Artificial Intelligence for Engineering Biology Consortium, among others. Her research focuses on synthetic biology, host-aware cell engineering, and the integration of computational biology with AI for synthetic design. She has developed tools to mitigate cellular burden in engineered systems and pioneered work on synthetic cells for therapeutic applications. Dr. Ceroni earned her BSc, MRes, and PhD in Bioengineering from the University of Bologna. Her postdoctoral training included a Visiting Research Fellowship at Harvard Medical School and roles at Imperial College London, where she became a Junior Research Fellow in 2016. Her work bridges engineering principles with biological systems, emphasizing ethical and biosecurity considerations in synthetic biology. Her research spans six core areas: host-aware engineering of mammalian and bacterial cells, computational biology/AI-driven design, engineered synthetic cells, gene expression control, and biosecurity governance. Key contributions include identifying resource competition in engineered cells and developing non-invasive assays for cell growth characterization. Her team collaborates with industry partners like AZ and Bayer to translate findings into biomedical applications. Education: BSc in Pharmaceutical Biotechnologies, University of Bologna (2001–2004) MRes in Bioengineering, University of Bologna (2004–2007) PhD in Bioengineering, University of Bologna (2008–2011) Dr. Ceroni has been recognized with the 2016 Junior Research Fellowship from Imperial College London. Her work is published in high-impact journals like Nature Communications , Nature Reviews Bioengineering , and Science , with a focus on advancing synthetic biology’s technical and ethical dimensions.